Top Markets
#1 Akedo Akedo +57.11%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.98%
#4 Velvet Velvet +42.35%
#5 Black Phoenix Black Phoenix +34.56%
#6 Ο„emplar Ο„emplar +28.04%
#7 Ribbita by Virtuals Ribbita by Virtuals +19.92%
#8 Bitway Bitway +17.09%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.98%
#10 Cap Cap +16.13%
Coin of the day
Akedo Akedo
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
CohBar, Inc. CohBar, Inc.

CohBar, Inc.

CWBR
Kedudukan dalam Saham #38304
CohBar Inc. is a clinical-stage biotechnology company dedicated to the... CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.
Harga Saham
$0.41
Disegerakkan terakhir: 2025-01-23
Modal Pasaran
$1.08M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan CohBar, Inc. (CWBR)

Kategori

Healthcare
Bilangan saham terbitan bagi CohBar, Inc. (CWBR)
Bilangan saham terbitan setakat June 2023: 2.91M
Menurut laporan kewangan terkini dan harga saham CohBar, Inc., bilangan saham terbitan semasa ialah 2.91M. Pada akhir December 2021, syarikat mempunyai 2.22M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk CohBar, Inc. (CWBR) dari 2012 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 2.91M 0.31%
2022 2.90M 30.54%
2021 2.22M 36.45%
2020 1.63M 14.02%
2019 1.43M 3.78%
2018 1.38M 10.09%
2017 1.25M 13.13%
2016 1.10M 3.37%
2015 1.07M 80.48%
2014 591.75K 37.62%
2013 430.00K 6.70%
2012 403.00K 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 8,634.31%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 2,039.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE